From our first foundations, led by cardiologists – including our founder and Medical Director Dr Harry Mond – we’ve always looked at advances that deliver faster, higher quality cardiac data.
This single idea, to speed up diagnosis to get to the heart of the matter for cardiologists and their patients, led us to BeatBox, our global cardiac platform.
Developed by our parent company – CardioScan – to meet own growing global demand, it solved challenges of manual handling, error risks and time lag communication – and instead made mobile cardiac reporting and instant data access possible.
Today, we deliver among the fastest turnarounds on volume cardiac data globally and our medical knowledge remains at our core, with quality assurance standards that remain unmatched.
Now in eight countries, including the US, Australia, United Kingdom and Asia, we continue to grow to meet demand for our leading cardiac monitoring services.
Cardiac Monitoring Services Medical Director Dr Harry Mond is a founding member of our parent company CardioScan, and remains among the world’s top experts in the interpretation of ECG and Holter studies.
As an international educator and author of 275+ peer-reviewed manuscripts and books, he provides regular training and professional development to our team of certified cardiac technicians to ensure the highest clinical standards.
Download Dr Mond’s full profile here.
Jeremy Steele is our current CEO and has been on the Board of Cardiac Monitoring Services parent company CardioScan since 2012. Jeremy has more than 25 years of corporate experience across a wide range of industries including healthcare, software, financial services and retail. Jeremy has worked extensively with many growing business to drive their expansion both in Australia and abroad. Jeremy holds a B. Com from the University of Adelaide and was awarded a Future Leader Award at the 2007 Australia Future Summit.
Rudy Watkins is the CEO of CardioScan’s US business, Cardiac Monitoring Service, and has more than 37 years of healthcare industry experience.
Most recently, he spent seven years as the Chief Commercial / Revenue Officer at AirStrip, where he was responsible for Revenue, Sales, Marketing, Business Development, Partnerships, Client Implementations and Account Management. Rudy also spent 30 years at GE Healthcare as GM leading the Patient Care Solutions IT Sales and Marketing division and VP leadership roles in HIT partnerships, professional services, operations and commercial management.
Suzanne Coulston joined Cardiac Monitoring Services in 2001 and under her leadership CMS has become a leader in the field of Cardiac Services in the United States.
She brings more than 20 years of expertise in customer service and account management and is diligent and committed to making sure that each patient, physician and staff member receive the first-class level of service that sets Cardiac Monitoring Services apart.
Delivered by leading cardiologists and highly qualified cardiac technicians – along exacting quality assurance standards to ensure accurate diagnostic results.
Together with strong leadership in all our regions, we continue to deliver technology that helps you keep pace and improve patient outcomes.
Josh Casey is the Head of Strategy and Finance at CardioScan. He brings over 10 years’ experience in mid-market private businesses in an investment, advisory and management capacity.
Josh holds a Masters of Applied Finance from Macquarie University, is a graduate of the ICAA and holds a Commerce degree from the University of Melbourne.
Asaf Ziv is CardioScan’s CTO with extensive knowledge and experience in the Medical imaging and ICT industry. With an exceptional track record of enterprise health projects world-wide and system integration management, Asaf has more than 9 years of experience in Project Management in the health industry and over 10 years of experience in the ICT field. As Chief Technology Officer, Asaf is responsible for planning and executing technology strategies, system architecture designs and IT projects.
Thungar oversees our Local and International clinical teams, bringing many years of in depth experience in arrhythmia analysis.
He has more than 20 years in the cardiac field, including more than 15 years at CardioScan. Thungar holds a Bachelor of Science degree from Monash University, a Post-graduate Diploma in Science from La Trobe University and Certificate III in Electrocardiography for Technicians.
Mark Deady has spent over 20 years leading high-performing IT operations and support teams and managing the governance, design and implementation of IT services and security solutions in enterprise environments. He has a number of years’ experience in the healthcare industry, recently consulting at Bupa to design and deliver an Identity and Access Management solution across Australia and New Zealand. Mark holds a Bachelor of Science and a Graduate Diploma in Digital Communications from Monash University.
Cardiac Monitoring Service’s Head of Pediatric Cardiology, Dr. Brian Edis, has over 49 years experience practising as a pediatric cardiologist in both Australia and the US, including at the Royal Children’s Hospital (Melbourne) and Royal Women’s Hospital in neonatal and fetal echocardiography. Although retired from clinical consultancy, he continues in Pediatric ECG and Holter reporting. Dr Edis has dedicated his life to improving patient care and provides regular training and professional insights to Cardiac Monitoring Service’s team of certified cardiac technicians.
Thibaut de Cours leads our CardioScan UK business. Thibaut has more than 15 years of entrepreneurial experience in commercialising health technologies that improve clinical processes within hospitals or across health economies. Thibaut graduated with an MBA from the Wharton School of the University of Pennsylvania in the USA and a BA in business from ESC Amiens in France.
Francis Chan is the General Manager of CardioScan Hong Kong. Francis is also the founder of Leon Medical Supplies and Chariot Pharma Ltd, a Hong Kong company distributing medical devices, generic drugs and health supplements to clinics, hospitals and pharmacies in Hong Kong and Macau for more than 15 years.
Alongside his position as CardioScan Malaysia GM, David Yeoh is the founder and CEO of Beurotech Sdn Bhd, a Malaysian company providing medical devices for Johnson & Johnson and other major medical brands, distributing to clinics, hospitals and pharmacies for more than 9 years. Previously, David worked at Johnson and Johnson specialising in diabetes care for 6 years. He holds a Bachelor of Business Administration from Western Michigan University.
Mahathir Jamah is the General Manager of CardioScan Singapore, and is a Director of Business Development, Procurement and Facilities at our joint venture partner Singapore Medical Group, a listed primary health care provider in Singapore.
Prior to this role he has a background as an application developer at Wired Media and graduated from the University of Portsmouth with a Bachelor of Accountancy and Financial Management, along with a Diploma of Computer Information Systems from Singapore Polytechnic.
2020 has served a plethora of different clinical cases where we've explored and analysed fascinating conditions from Atrial Fibrillation, Wenckeback AV block to bizarre cases of dual chamber pacing. To wrap up 2020, we've rounded up the top 10 cases by order of popularity.Read more
New miniaturized waterproof devices shifted the conversation in cardiac monitoring a few years ago. No longer restricted by large, cumbersome devices and wired electrodes, patients were now fitted with lightweight wearable Holters – remaining comfortable, even showering and exercising, for longer periods of up to...Read more
As a relatively new indication for ambulatory ECG monitoring, the use of Holters for detection of atrial fibrillation in patients with cryptogenic stroke can be limiting without appropriate investigation methods. As part of Stroke Month, Medical Director Assoc Prof Harry Mond shares this clinical note...Read more
As the coronavirus pandemic continues, facility resources continue to be stretched. While most of these resources are being focused on responding to the coronavirus, other essential health services, including cardiac services, are important for patients to access. Cardiovascular disease remains the number one cause of...Read more
Cardiac Monitoring Service provides this Service Impact Statement for customers needing to manage COVID-19 and its emerging impacts in our health sector. We will continue to keep you notified of any changes to our services, as we remain focused on continued service at this time....Read more